Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Holding DNTH?
Track your performance easily
See the Price Targets and Ratings of:
DNTH Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DNTH Stock 12 Month Forecast
Average Price Target
$47.75
▲(64.32% Upside)
| Highest Price Target$58.00 | Average Price Target$47.75 | Lowest Price Target$40.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
Reiterated
11/07/24
Robert W. Baird
Reiterated
10/07/24
Guggenheim
Reiterated
10/04/24
H.C. Wainwright
Reiterated
09/26/24
Wedbush
Reiterated
08/09/24
Cantor Fitzgerald
―
Buy
―
Initiated
06/27/24
Dianthus initiated with an Overweight at Cantor FitzgeraldDianthus initiated with an Overweight at Cantor Fitzgerald
Raymond James
$34→$51
Buy
75.50%
Upside
Reiterated
04/18/24
Dianthus price target raised to $51 from $34 at Raymond JamesDianthus price target raised to $51 from $34 at Raymond James
Stifel Nicolaus
$44
Buy
51.41%
Upside
Reiterated
03/22/24
Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), Dianthus Therapeutics (NASDAQ: DNTH) and Eli Lilly & Co (NYSE: LLY)
Jefferies
$22→$39
Buy
34.21%
Upside
Reiterated
03/22/24
Dianthus Therapeutics (DNTH) PT Raised to $39 at JefferiesJefferies analyst Maury Raycroft raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $39.00 (from $22.00) while maintaining a Buy rating.
―
Oppenheimer
―
Buy
―
Initiated
10/02/24
Oppenheimer starts Dianthus Therapeutics (DNTH) at OutperformOppenheimer initiates coverage on Dianthus Therapeutics (NASDAQ: DNTH) with a Outperform rating and a price target of $48.00.
Best Analysts Covering Dianthus Therapeutics
Which Analyst Should I Follow If I Want to Buy DNTH and Sell After:
1 Month
xxx
Success Rate
4/6 ratings generated profit
Average Return
+6.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +6.50% per trade.
3 Months
xxx
Success Rate
3/3 ratings generated profit
Average Return
+8.90%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +8.90% per trade.
1 Year
Success Rate
3/3 ratings generated profit
Average Return
+9.30%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.30% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+9.30%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +9.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DNTH Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
7
8
6
5
3
Buy
1
2
2
3
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
10
8
8
5
Each month's total comprises the sum of three months' worth of ratings.
DNTH Financial Forecast
DNTH Stock Forecast FAQ
What is DNTH’s average 12-month price target, according to analysts?
Based on analyst ratings, Dianthus Therapeutics’s 12-month average price target is $47.75.
What is DNTH’s upside potential, based on the analysts’ average price target?
Dianthus Therapeutics has 64.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DNTH a Buy, Sell or Hold?
Dianthus Therapeutics has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Dianthus Therapeutics’s price target?
The average price target for Dianthus Therapeutics is $47.75. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $58.00 ,the lowest forecast is $40.00. The average price target represents 64.32% Increase from the current price of $29.06.
The highest analyst price target is $58.00 ,the lowest forecast is $40.00. The average price target represents 64.32% Increase from the current price of $29.06.
What do analysts say about Dianthus Therapeutics?
Dianthus Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of DNTH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.